Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Appointed director

Evofem Biosciences, Inc. (EVFM) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/26/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/31/2022 4 PELLETIER SAUNDRA L (CEO) has filed a Form 4 on Evofem Biosciences, Inc.
Txns: Bought 141,000 shares @ $0.3525, valued at $49.7k
05/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/23/2022 4 Fitzpatrick Alexander A (General Counsel and Secretary) has filed a Form 4 on Evofem Biosciences, Inc.
Txns: Granted 300,000 shares @ $0
Granted 300,000 options to buy @ $0.49, valued at $147k
02/23/2022 4 File Justin J. (CFO) has filed a Form 4 on Evofem Biosciences, Inc.
Txns: Granted 450,000 shares @ $0
Granted 450,000 options to buy @ $0.49, valued at $220.5k
02/23/2022 4 PELLETIER SAUNDRA L (CEO) has filed a Form 4 on Evofem Biosciences, Inc.
Txns: Granted 750,000 shares @ $0
Granted 750,000 options to buy @ $0.49, valued at $367.5k
01/04/2022 4 Fitzpatrick Alexander A (General Counsel and Secretary) has filed a Form 4 on Evofem Biosciences, Inc.
Txns: Disposed/sold 120,000 shares @ $0
01/04/2022 4 File Justin J. (CFO) has filed a Form 4 on Evofem Biosciences, Inc.
Txns: Disposed/sold 120,000 shares @ $0
01/04/2022 4 PELLETIER SAUNDRA L (CEO) has filed a Form 4 on Evofem Biosciences, Inc.
Txns: Disposed/sold 300,000 shares @ $0
12/20/2021 4 Fitzpatrick Alexander A (General Counsel and Secretary) has filed a Form 4 on Evofem Biosciences, Inc.
Txns: Bought 25,000 shares @ $0.389, valued at $9.7k
12/20/2021 4 File Justin J. (CFO) has filed a Form 4 on Evofem Biosciences, Inc.
Txns: Bought 40,594 shares @ $0.37, valued at $15k
12/20/2021 4 PELLETIER SAUNDRA L (CEO) has filed a Form 4 on Evofem Biosciences, Inc.
Txns: Bought 135,000 shares @ $0.375, valued at $50.6k
07/09/2021 4 Barrans Russell (Chief Commercial Officer) has filed a Form 4 on Evofem Biosciences, Inc.
Txns: Paid exercise price by delivering 19,998 shares @ $0.975, valued at $19.5k
06/21/2021 4 Kamdar Kim P. (Director) has filed a Form 4 on Evofem Biosciences, Inc.
Txns: Bought 10,000 shares @ $1.165, valued at $11.7k
06/14/2021 4 Rarick Lisa Dale (Director) has filed a Form 4 on Evofem Biosciences, Inc.
Txns: Bought 5,000 shares @ $1.198, valued at $6k
06/14/2021 4 O'Brien Anthony Stephen (Director) has filed a Form 4 on Evofem Biosciences, Inc.
Txns: Bought 8,140 shares @ $1.31, valued at $10.7k
06/11/2021 4 Barrans Russell (Chief Commercial Officer) has filed a Form 4 on Evofem Biosciences, Inc.
Txns: Bought 18,180 shares @ $1.14, valued at $20.7k
06/10/2021 4 File Justin J. (CFO) has filed a Form 4 on Evofem Biosciences, Inc.
Txns: Bought 24,500 shares @ $1.03, valued at $25.2k
06/10/2021 4 PELLETIER SAUNDRA L (CEO) has filed a Form 4 on Evofem Biosciences, Inc.
Txns: Bought 50,000 shares @ $1.03, valued at $51.5k
06/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/21/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/21/2021 4 Barrans Russell (Chief Commercial Officer) has filed a Form 4 on Evofem Biosciences, Inc.
Txns: Paid exercise price by delivering 31,480 shares @ $0.86, valued at $27.1k
05/21/2021 4 Culwell Kelly (Chief Medical Officer) has filed a Form 4 on Evofem Biosciences, Inc.
Txns: Paid exercise price by delivering 42,061 shares @ $0.86, valued at $36.2k
05/21/2021 4 File Justin J. (CFO) has filed a Form 4 on Evofem Biosciences, Inc.
Txns: Paid exercise price by delivering 42,280 shares @ $0.86, valued at $36.4k
05/21/2021 4 PELLETIER SAUNDRA L (CEO) has filed a Form 4 on Evofem Biosciences, Inc.
Txns: Paid exercise price by delivering 105,300 shares @ $0.86, valued at $90.6k
05/13/2021 4 Greer Gillian (Director) has filed a Form 4 on Evofem Biosciences, Inc.
Txns: Granted 90,000 options to buy @ $1.25, valued at $112.5k
05/13/2021 4 Rutherford Colin (Director) has filed a Form 4 on Evofem Biosciences, Inc.
Txns: Granted 90,000 options to buy @ $1.25, valued at $112.5k
05/13/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/13/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/13/2021 4 O'Brien Anthony Stephen (Director) has filed a Form 4 on Evofem Biosciences, Inc.
Txns: Granted 90,000 options to buy @ $1.25, valued at $112.5k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy